Ozempic Generics Pricing Could Drop Below $100 a Month, Claims Sanders
Sen. Sanders Advocates for Affordable Ozempic Generics
Sen. Bernie Sanders of Vermont revealed a groundbreaking assertion at a Senate health committee roundtable: generics of Novo Nordisk's Ozempic could be produced and sold for less than $100 a month. Currently, patients endure exorbitant costs approaching $1,000 monthly in the U.S. As a response, Sanders emphasized the potential of generics, citing discussions with various major generics companies.
Highlighting the Drug Cost Crisis
Sanders expressed concern that prices for Ozempic and related drugs like Wegovy threaten to bankrupt Medicare, Medicaid, and the healthcare system. The disparity in pricing is staggering—whereas U.S. patients pay nearly $1,000, those in Canada and Germany pay just $155 and $59, respectively. In a stark contrast, he pointed out that a study in the Journal of the American Medical Association found that injectable semaglutide could be profitably made for less than $5 a month.
Disclaimer: The information provided on this site is for informational purposes only and is not intended as medical advice. We are not responsible for any actions taken based on the content of this site. Always consult a qualified healthcare provider for medical advice, diagnosis, and treatment. We source our news from reputable sources and provide links to the original articles. We do not endorse or assume responsibility for the accuracy of the information contained in external sources.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.